Form 4: Phreesia SVP David Linetsky Sells Shares to Cover Tax Obligations

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 2,011 shares of common stock to cover tax withholding obligations.

Summary

• On October 15, 2024, David Linetsky, SVP of Life Sciences at Phreesia, Inc., disposed of 2,011 shares of common stock.
• The shares were sold at a weighted average price of $21.0251 per share, with individual transactions ranging from $20.755 to $21.34.
• The sale was conducted to cover tax withholding obligations related to the settlement of restricted stock units, as per the issuer's mandatory sell-to-cover policy.
• Following the transaction, Linetsky directly owns 201,307 shares of common stock and indirectly owns 8,971 shares through his spouse.

Sentiment

Score: 5

Explanation: The document reflects a neutral sentiment as it reports a routine stock sale for tax purposes, without any indication of positive or negative outlook.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, related to tax obligations, and doesn't necessarily indicate a change in sentiment regarding the company's prospects.

Comparison to Industry Standards

• Sell-to-cover transactions are a common practice among executives receiving stock-based compensation.
• The volume of shares sold is relatively small compared to Linetsky's total holdings, suggesting it's a routine transaction rather than a significant divestment.
• Comparable companies in the tech and healthcare sectors often have similar policies in place for managing tax obligations related to equity compensation.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a routine sale to cover tax obligations.

Key Dates